Lupus Anticoagulants, Anticardiolipin Antibodies, and Fetal Loss: A Case–Control Study
Open Access
- 10 October 1991
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 325 (15) , 1063-1066
- https://doi.org/10.1056/nejm199110103251503
Abstract
Lupus anticoagulants and anticardiolipin antibodies are antiphospholipid antibodies that have been associated with fetal loss, but they have not been shown unequivocally to be a risk factor for this event.Keywords
This publication has 23 references indexed in Scilit:
- Recurrent miscarriage I: definition and epidemiologyThe Lancet, 1990
- ANTIPHOSPHOLIPID ANTIBODIESBritish Journal of Haematology, 1990
- Antiphospholipid Antibodies and Recurrent Pregnancy LossAmerican Journal of Reproductive Immunology, 1989
- Modeling and variable selection in epidemiologic analysis.American Journal of Public Health, 1989
- Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibodyAmerican Journal of Obstetrics and Gynecology, 1989
- Lupus anticoagulant in women with multiple spontaneous miscarriageAmerican Journal of Hematology, 1987
- On the role of ‘habitual aborters’ in the analysis of spontaneous abortionStatistics in Medicine, 1986
- Antibody to Cardiolipin as a Predictor of Fetal Distress or Death in Pregnant Patients with Systemic Lupus ErythematosusNew England Journal of Medicine, 1985
- Thromboembolism in patients with the 'lupus'-type circulating anticoagulantArchives of internal medicine (1960), 1984
- Demonstration of a platelet bypass mechanism in the clotting system using an acquired anticoagulantAmerican Journal of Hematology, 1978